WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), currently valued at $535 million, announced positive results from the Phase 2 VERONA clinical trial of DURAVYU™, its ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...
GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...
ALAN CARR fears an eye condition will ruin his eyesight after having a “worrying” diagnostic test. The 48-year-old Chatty Man ...
The doctor highlighted a link between increased urination and sudden weight loss as potential early indicators of diabetes, ...
The increased urination can also lead to a loss of fluid contributing to this weight loss. Finally, the fourth common ...
Pycnogenol French maritime pine bark extract as part of a healthier lifestyle contributes to the reduction of high blood ...
As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, ...
Symptoms and causes of gastroparesis ... Diagnosis of gastroparesis. American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in ...
The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and underserved regions where access to retina specialists is limited. By automating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback